Preview environment — 8 connected services are simulated, and anything they create is labelled. See what is live
Skin & Hair
Second line — by exceptionNot a controlled substanceCompounded by a 503A pharmacy

Finasteride + Minoxidil

Combination therapy for androgenic hair loss

Oral finasteride paired with topical minoxidil is the best-evidenced combination for male-pattern hair loss. Compounded together into a single topical where systemic finasteride is not appropriate.

This is not where treatment usually starts. It is prescribed when the manufactured, FDA-approved option has been ruled out for you specifically, and your nurse practitioner has to write down why before it can be sent to a pharmacy. You are welcome to ask about it — just expect the conversation.

Regulatory status

Compounded combination preparation. Not FDA-approved. Both actives are individually FDA-approved.

Topical hair restoration therapy

Frequency

Daily

Route

Topical

Supply

90-day supply

Minimum age

18+

What it does

What patients get from this

  • Halts progression in the large majority of patients
  • Regrowth typically visible at 4 to 6 months
  • Topical formulation limits systemic exposure
  • Photo progress tracking in your portal

We will not prescribe this if

  • Pregnancy, breastfeeding, or female of childbearing potential
  • History of prostate cancer
  • Known hypersensitivity to either active

The intake asks about each of these. Some answers stop the process; others are flagged for your nurse practitioner.

Labs your NP may order

  • PSA (men over 40)

Draw at our Fort Lauderdale clinic or a reference lab near you. Your NP reviews the results and posts them to your account.

Please read

  • Compounded drugs are not FDA-approved and have not been evaluated by FDA for safety or effectiveness.
  • Finasteride is contraindicated in women who are or may become pregnant.
  • Sexual side effects are reported in a minority of patients and are usually reversible on discontinuation.

About compounded medication

A compounded preparation is made for one named patient by a licensed pharmacy. It is not an FDA-approved product: the FDA does not review it for safety, effectiveness or manufacturing quality. Your nurse practitioner has to record a specific clinical reason why the commercially available product will not work for you before this can be prescribed — and cost on its own is not one.

A 503A pharmacy may not supply a clinic with shared stock, so your prescription is filled in your name and shipped to the clinic for you. A nurse cannot administer it without linking the order it came from.